Emily R.W. Davidson, MD

Emily R. W. Davidson, MD

Assistant Professor, Obstetrics & Gynecology

Education

MD, University of Chicago, Pritzker School of Medicine, Chicago, IL
Residency in Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Fellowship in Female Pelvic Medicine & Reconstructive Surgery, Cleveland Clinic, Cleveland, OH

View physician profile

Biography

Dr. Davidson is a board-certified physician in Obstetrics and Gynecology, specializing in Female Pelvic Medicine and Reconstructive Surgery (commonly known as Urogynecology). Dr. Davidson is committed to creating a safe environment where patients can discuss quality of life issues, such as incontinence and pelvic organ prolapse. Together, she and her patients create treatment plans to meet patient-centered goals of care. Her research interests include improving care delivery for pelvic floor disorders as well as appropriate opioid prescribing.

Research Experience

Analgesics, Opioid
Hysterectomy, Vaginal
Pain, Postoperative
Pelvic Organ Prolapse
Urinary Bladder, Overactive
Urinary Incontinence

Differences in fatigability of muscles involved in fecal continence: Potential clinical ramifications.

(Patel K, Mei L, Yu E, Kern M, Lehal N, Edeani F, Sanvanson P, Davidson ERW, Shaker R.) Physiol Rep. 2021 12;9(24):e15144 PMID: 34927399 PMCID: PMC8685596 SCOPUS ID: 2-s2.0-85121744043 12/21/2021
Perioperative outcomes following pelvic floor reconstruction in women with hereditary disorders of connective tissue: a retrospective cohort study.

(Davidson ERW, Alam PA, Byrnes JN, Bochenska K, Florian-Rodriguez M, Carter-Brooks CM, Myer ENB, Tefera EA, Good MM, Gutman RE.) Int Urogynecol J. 2021 Aug;32(8):2135-2142 PMID: 34213599 07/03/2021
Predictors for Pelvic Organ Prolapse Recurrence After Sacrocolpopexy: A Matched Case-Control Study.

(Chang OH, Davidson ERW, Thomas TN, Paraiso MFR, Ferrando CA.) Female Pelvic Med Reconstr Surg. 2021 01 01;27(1):e165-e170 PMID: 32282526 04/14/2020
Our Professional Responsibility and Social Media: A Call to Action in Female Pelvic Medicine and Reconstructive Surgery.

(Brown O, Davidson ERW, Fitzgerald JJ.) Female Pelvic Med Reconstr Surg. 2020 12 01;26(12):721-722 PMID: 33555817 02/09/2021
Pelvic organ prolapse recurrence in young women undergoing vaginal and abdominal colpopexy.

(Hickman LC, Tran MC, Davidson ERW, Walters MD, Ferrando CA.) Int Urogynecol J. 2020 Dec;31(12):2661-2667 PMID: 31828397 12/13/2019
Pelvic Organ Prolapse Recurrence and Patient-Centered Outcomes Following Minimally Invasive Abdominal Uterosacral Ligament and Mesh-Augmented Sacrohysteropexy.

(Davidson ERW, Casas-Puig V, Paraiso MFR, Ridgeway B, Ferrando CA.) Female Pelvic Med Reconstr Surg. 2020 12 01;26(12):763-768 PMID: 30845072 03/08/2019
A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair.

(Davidson ERW, Paraiso MFR, Walters MD, Propst K, Ridgeway B, Yao M, Ferrando CA.) Am J Obstet Gynecol. 2020 10;223(4):547.e1-547.e12 PMID: 32199926 03/23/2020
Does concurrent posterior repair for an asymptomatic rectocele reduce the risk of surgical failure in patients undergoing sacrocolpopexy?

(Chang OH, Davidson ERW, Thomas TN, Paraiso MFR, Ferrando CA.) Int Urogynecol J. 2020 10;31(10):2075-2080 PMID: 32146522 03/09/2020
Long-term pelvic organ prolapse recurrence and mesh exposure following sacrocolpopexy.

(Thomas TN, Davidson ERW, Lampert EJ, Paraiso MFR, Ferrando CA.) Int Urogynecol J. 2020 Sep;31(9):1763-1770 PMID: 32253489 04/08/2020
Patient-Centered Outcomes After Modified Vestibulectomy.

(Das D, Davidson ERW, Walters M, Farrell RM, Ferrando CA.) Obstet Gynecol. 2020 01;135(1):113-121 PMID: 31809431 12/07/2019
Perioperative adverse events in women undergoing concurrent urogynecologic and gynecologic oncology surgeries for suspected malignancy.

(Davidson ERW, Woodburn K, AlHilli M, Ferrando CA.) Int Urogynecol J. 2019 07;30(7):1195-1201 PMID: 30280203 10/04/2018
Route of hysterectomy during minimally invasive sacrocolpopexy does not affect postoperative outcomes.

(Davidson ERW, Thomas TN, Lampert EJ, Paraiso MFR, Ferrando CA.) Int Urogynecol J. 2019 04;30(4):649-655 PMID: 30338370 10/20/2018